cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.ghyauw
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (Alsophis antiguae Parker, 1933)",
 "OccurrenceStatus is Present",
 "Year is greater than or equal to 2000",
 "BasisOfRecord is one of (Human Observation, Observation, Machine Observation)",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 {
 "or" : [
 "CoordinateUncertaintyInMeters is less than 100",
 "CoordinateUncertaintyInMeters is null"
 ]
 }
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0084240-240626123714530/datasets/export for details.
DOI: 10.13012/b2idb-6010827_v1
title: Data for Jones et al. GCB-23-1273.R1

description: Dataset associated with Jones et al. GCB-23-1273.R1 submission: Phenotypic signatures of urbanization? Resident, but not migratory, songbird eye size varies with urban-associated light pollution levels. Excel CSV file with all of the data used in analyses and file with descriptions of each column.
DOI: 10.15468/dl.ne2gqs
title: Occurrence Download

description: A dataset containing 4155 species occurrences available in GBIF matching the query:
{
 "and" : [
 {
 "and" : [
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 {
 "not" : {
 "BasisOfRecord" : [
 "is one of (Fossil, Living Specimen)"
 ]
 }
 }
 ]
 },
 "SpeciesKey is Ancylis unguicella (Linnaeus, 1758)",
 "Year is greater than or equal to 2004",
 "Year is less than or equal to 2023"
 ]
}

 The dataset includes 4155 records from 65 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0084241-240626123714530/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.8kucc7
title: Occurrence Download

description: A dataset containing 29824 species occurrences available in GBIF matching the query:
{
 "and" : [
 {
 "and" : [
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 {
 "not" : {
 "BasisOfRecord" : [
 "is one of (Fossil, Living Specimen)"
 ]
 }
 }
 ]
 },
 "SpeciesKey is Leptinotarsa decemlineata (Say, 1824)",
 "Year is greater than or equal to 2004",
 "Year is less than or equal to 2023"
 ]
}

 The dataset includes 29824 records from 222 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0084242-240626123714530/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.24681066
title: Long-term effects of widespread pharmaceutical pollution on trade-offs between behavioural, life-history, and reproductive traits in fish

description: In our rapidly changing world, understanding how species respond to shifting conditions is of paramount importance. Pharmaceutical pollutants—ubiquitous in aquatic ecosystems globally—are a major ecological concern. Yet their impacts on animal behaviour, life history, and reproductive investment remain poorly understood, especially in the context of intraspecific variation in ecologically important traits that facilitate species’ adaptive capacities. We test whether a widespread pharmaceutical pollutant, fluoxetine (Prozac), disrupts the trade-off between individual-level (co)variation in behavioural, life history, and reproductive traits of wildlife. To do so, we exposed the progeny of wild-caught guppies (<i>Poecilia reticulata</i>) to environmentally realistic levels of fluoxetine for five years, across multiple generations. We used 12 independent laboratory populations and repeatedly quantified activity and risk-taking behaviour of male guppies, capturing both mean behaviours and variation within and among individuals across exposure treatments. We also measured key life-history traits (body condition, colouration, and gonopodium size) and assessed post-copulatory sperm traits (sperm vitality, number, and velocity) that are known to be under strong sexual selection in polyandrous species. Intraspecific (co)variation of these traits was analysed using a comprehensive, multivariate statistical approach. At the population level, fluoxetine had a dose-specific (mean) effect on the life history and sperm traits of guppies: pollutant exposure improved male body condition and increased gonopodium size, but reduced sperm velocity. At the individual level, fluoxetine reduced the behavioural plasticity of guppies by eroding their within-individual variation in both activity and risk-taking behaviour. Fluoxetine also altered among-individual correlations between pace-of-life syndrome traits: it triggered the emergence of correlations between behavioural and life-history traits (e.g., activity and body condition) and between life-history and sperm traits (e.g., gonopodium size and sperm vitality), but collapsed other among-individual correlations (e.g.,  activity and gonopodium size). Our results reveal that chronic exposure to global pollutants can affect phenotypic traits at both population and individual levels, and even alter individual-level correlations among such traits in a dose-specific manner. Our work highlights the need to integrate individual-level analyses and test behaviour in association with life-history and reproductive traits to fully understand how animals adjust to human-induced environmental change.
DOI: 10.6084/m9.figshare.24681066.v1
title: Long-term effects of widespread pharmaceutical pollution on trade-offs between behavioural, life-history, and reproductive traits in fish

description: In our rapidly changing world, understanding how species respond to shifting conditions is of paramount importance. Pharmaceutical pollutants—ubiquitous in aquatic ecosystems globally—are a major ecological concern. Yet their impacts on animal behaviour, life history, and reproductive investment remain poorly understood, especially in the context of intraspecific variation in ecologically important traits that facilitate species’ adaptive capacities. We test whether a widespread pharmaceutical pollutant, fluoxetine (Prozac), disrupts the trade-off between individual-level (co)variation in behavioural, life history, and reproductive traits of wildlife. To do so, we exposed the progeny of wild-caught guppies (<i>Poecilia reticulata</i>) to environmentally realistic levels of fluoxetine for five years, across multiple generations. We used 12 independent laboratory populations and repeatedly quantified activity and risk-taking behaviour of male guppies, capturing both mean behaviours and variation within and among individuals across exposure treatments. We also measured key life-history traits (body condition, colouration, and gonopodium size) and assessed post-copulatory sperm traits (sperm vitality, number, and velocity) that are known to be under strong sexual selection in polyandrous species. Intraspecific (co)variation of these traits was analysed using a comprehensive, multivariate statistical approach. At the population level, fluoxetine had a dose-specific (mean) effect on the life history and sperm traits of guppies: pollutant exposure improved male body condition and increased gonopodium size, but reduced sperm velocity. At the individual level, fluoxetine reduced the behavioural plasticity of guppies by eroding their within-individual variation in both activity and risk-taking behaviour. Fluoxetine also altered among-individual correlations between pace-of-life syndrome traits: it triggered the emergence of correlations between behavioural and life-history traits (e.g., activity and body condition) and between life-history and sperm traits (e.g., gonopodium size and sperm vitality), but collapsed other among-individual correlations (e.g.,  activity and gonopodium size). Our results reveal that chronic exposure to global pollutants can affect phenotypic traits at both population and individual levels, and even alter individual-level correlations among such traits in a dose-specific manner. Our work highlights the need to integrate individual-level analyses and test behaviour in association with life-history and reproductive traits to fully understand how animals adjust to human-induced environmental change.
DOI: 10.15468/dl.wzxgbt
title: Occurrence Download

description: A dataset containing 231 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Limonium tournefortii (Boiss.) Erben"
 ]
}

 The dataset includes 231 records from 26 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0046736-240321170329656/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.94fv3y
title: Occurrence Download

description: A dataset containing 1 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Liparis tigerhillensis A.P.Das & Chanda"
 ]
}

 The dataset includes 1 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0046737-240321170329656/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.z9caq2
title: Occurrence Download

description: A dataset containing 1 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Liparis togensis J.J.Sm."
 ]
}

 The dataset includes 1 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0046739-240321170329656/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.w8k6dp
title: Occurrence Download

description: A dataset containing 2 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Limonium trachycladum Maire & Wilczek"
 ]
}

 The dataset includes 2 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0046738-240321170329656/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.pa4sk4
title: Occurrence Download

description: A dataset containing 26 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Noccaea tymphaea (Hausskn.) F.K.Mey."
 ]
}

 The dataset includes 26 records from 9 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0046740-240321170329656/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.zvg6t6
title: Occurrence Download

description: A dataset containing 6 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Liparis torricellensis Schltr."
 ]
}

 The dataset includes 6 records from 5 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0046741-240321170329656/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.9z5tg7
title: Occurrence Download

description: A dataset containing 365 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Limonium tremolsii (Rouy) Erben"
 ]
}

 The dataset includes 365 records from 38 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0046742-240321170329656/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.fcu2qj
title: Occurrence Download

description: A dataset listing the 126 species recorded in GBIF matching the query:
{
 "and" : [
 "Country is Germany",
 "TaxonKey is Potamogeton L."
 ]
}

 The dataset's 126 records were derived from 207 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0046648-240321170329656/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.kp96us
title: Occurrence Download

description: A dataset containing 884 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Normandia neocaledonica Hook.f."
 ]
}

 The dataset includes 884 records from 30 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0046743-240321170329656/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.23937853
title: Can artificial intelligence separate the wheat from the chaff in systematic reviews of health economic articles?

description: Artificial intelligence-powered tools, such as ASReview, could reduce the burden of title and abstract screening. This study aimed to assess the accuracy and efficiency of using ASReview in a health economic context. A sample from a previous systematic literature review containing 4,994 articles was used. Previous manual screening resulted in 134 articles included for full-text screening (FT) and 50 for data extraction (DE). Here, accuracy and efficiency was evaluated by comparing the number of identified relevant articles with ASReview versus manual screening. Pre-defined stopping rules using sampling criteria and heuristic criteria were tested. Robustness of the AI-tool’s performance was determined using 1,000 simulations. Considering included stopping rules, median accuracy for FT articles remained below 85%, but reached 100% for DE articles. To identify all relevant articles, a median of 89.9% of FT articles needed to be screened, compared to 7.7% for DE articles. Potential time savings between 49 and 59 hours could be achieved, depending on the stopping rule. In our case study, all DE articles were identified after screening 7.7% of the sample, allowing for substantial time savings. ASReview likely has the potential to substantially reduce screening time in systematic reviews of health economic articles.
DOI: 10.6084/m9.figshare.23937853.v1
title: Can artificial intelligence separate the wheat from the chaff in systematic reviews of health economic articles?

description: Artificial intelligence-powered tools, such as ASReview, could reduce the burden of title and abstract screening. This study aimed to assess the accuracy and efficiency of using ASReview in a health economic context. A sample from a previous systematic literature review containing 4,994 articles was used. Previous manual screening resulted in 134 articles included for full-text screening (FT) and 50 for data extraction (DE). Here, accuracy and efficiency was evaluated by comparing the number of identified relevant articles with ASReview versus manual screening. Pre-defined stopping rules using sampling criteria and heuristic criteria were tested. Robustness of the AI-tool’s performance was determined using 1,000 simulations. Considering included stopping rules, median accuracy for FT articles remained below 85%, but reached 100% for DE articles. To identify all relevant articles, a median of 89.9% of FT articles needed to be screened, compared to 7.7% for DE articles. Potential time savings between 49 and 59 hours could be achieved, depending on the stopping rule. In our case study, all DE articles were identified after screening 7.7% of the sample, allowing for substantial time savings. ASReview likely has the potential to substantially reduce screening time in systematic reviews of health economic articles.
DOI: 10.15468/dl.nagr26
title: Occurrence Download

description: A dataset containing 1 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Liparis torta Hook.f."
 ]
}

 The dataset includes 1 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0046744-240321170329656/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.24088883
title: Evaluation of the economic benefits, administration times, and patient preferences associated with the use of biotechnological drugs administered subcutaneously and intravenously in patients with cancer: a systematic review

description: Cancer imposes a high economic burden with medical care and medication costs. We evaluate the costs, the use of resources, the administration time, and the patient preferences associated with the use of biotechnological drugs in SC and IV presentations. A systematic literature search was conducted in PubMed, Embase, and seven additional databases. The search was carried out in September 2021 and included only studies directly comparing SC and IV presentations. Evidence was synthesized narratively. 34 references were included, which only analyzed bortezomib, daratumumab, rituximab, and trastuzumab. Reduction in preparation costs of SC compared to IV presentations ranged from 6.6% to 50.1%, and in administration costs from 4.5% to 95.3%. SC administration of rituximab and trastuzumab resulted in less productivity loss. More than 68% of patients reported greater satisfaction with the SC route. A reduction of time in the infusion chair, lower costs of resources for preparation, and health personnel for the administration process were identified with SC administration. The use of SC daratumumab, rituximab, and trastuzumab in patients with cancer reduces direct and indirect costs and adverse events compared to IV use. Patients prefer the SC administration, perceiving more comfort, and less pain at the administration site.
DOI: 10.6084/m9.figshare.24088883.v1
title: Evaluation of the economic benefits, administration times, and patient preferences associated with the use of biotechnological drugs administered subcutaneously and intravenously in patients with cancer: a systematic review

description: Cancer imposes a high economic burden with medical care and medication costs. We evaluate the costs, the use of resources, the administration time, and the patient preferences associated with the use of biotechnological drugs in SC and IV presentations. A systematic literature search was conducted in PubMed, Embase, and seven additional databases. The search was carried out in September 2021 and included only studies directly comparing SC and IV presentations. Evidence was synthesized narratively. 34 references were included, which only analyzed bortezomib, daratumumab, rituximab, and trastuzumab. Reduction in preparation costs of SC compared to IV presentations ranged from 6.6% to 50.1%, and in administration costs from 4.5% to 95.3%. SC administration of rituximab and trastuzumab resulted in less productivity loss. More than 68% of patients reported greater satisfaction with the SC route. A reduction of time in the infusion chair, lower costs of resources for preparation, and health personnel for the administration process were identified with SC administration. The use of SC daratumumab, rituximab, and trastuzumab in patients with cancer reduces direct and indirect costs and adverse events compared to IV use. Patients prefer the SC administration, perceiving more comfort, and less pain at the administration site.
DOI: 10.6084/m9.figshare.25496884
title: Unwanted outcomes in cognitive behavior therapy for pathological health anxiety: a systematic review and a secondary original study of two randomized controlled trials

description: Cognitive behavior therapy (CBT) is effective for pathological health anxiety, but little is known about unwanted outcomes. We investigated unwanted outcomes in the form of adverse events, overall symptom deterioration, and dropouts in CBT for pathological health anxiety based on a systematic review of 19 randomized controlled trials (PubMed, PsycInfo, and OATD; last updated 2 June 2023; pooled <i>N</i> = 2188), and then a secondary original study of two randomized controlled trials (pooled <i>N</i> = 336). In the systematic review, 10% of participants in CBT reported at least one adverse event and 17% dropped out. Heterogeneity was substantial. In the original investigation, 17% reported at least one adverse event, 0–10% met criteria for overall symptom deterioration, and 10–19% dropped out. In guided Internet-delivered CBT, dropouts were more common with lower education and lower credibility/expectancy ratings. Higher adherence was associated with a larger reduction in health anxiety. Unwanted effects are routinely seen in CBT for pathological health anxiety, but, under typical circumstances, appear to be acceptable in light of the treatment’s efficacy. There is a need for more consistent methods to improve our understanding adverse events, dropouts, and overall symptom deterioration, and how these outcomes can be prevented. People who worry excessively about having or developing a serious disease are commonly offered cognitive behavior therapy (CBT). Little is known about unwanted outcomes in CBT for this patient group. This study had two parts. First, we conducted a systematic search of the existing literature where we found that about 10% of patients in CBT experience an event that they perceive as unwanted or negative. About 17% of patients drop out of treatment prematurely. Results differed substantially between studies. Second, we analyzed the outcome of two original studies and found that about 17% of patients in CBT experience an event that they perceive as unwanted or negative. Patients who experienced such an event reported, on average, a smaller reduction in health anxiety if CBT was delivered face-to-face, but not if it was delivered via the Internet. About 0–10% rated their health anxiety as having become worse after CBT, and 10–19% dropped out prematurely. In CBT delivered via the Internet, patients were more likely to drop out if their level of education was lower, and if they rated the treatment as less credible and expectancy-evoking during week 2. We conclude that unwanted effects are relatively common but typically mild and acceptable.